Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen vs Evening Primrose Oil in Benign Breast Disease
NCT00999921Phase 4Completed
- Sponsor
- Medical College and Hospital, Kolkata
- Start
- Jan 2008
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tamoxifen in benign breast disease (BBD), Fibrocystic breasts, fibroadenoma and 1 more, sponsored by Medical College and Hospital, Kolkata. Primary endpoints: Number of Participants Analysed for Reduction in Lump Size at 3 months and Number of Participants Analysed for Reduction in Mastalgia at 3 months. Started Jan 2008; status: completed.
02
Drugs
tamoxifen
03
Conditions
benign breast disease (BBD)Fibrocystic breastsfibroadenomamastalgia
Beyond the preview
Go deeper on NCT00999921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00999921.